These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 20712773

  • 1. Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease.
    Yannaki E, Stamatoyannopoulos G.
    Ann N Y Acad Sci; 2010 Aug; 1202():59-63. PubMed ID: 20712773
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
    Rosenbaum C, Peace D, Rich E, Van Besien K.
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):719-23. PubMed ID: 18489998
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P, Tuchman S, Larochelle A, Metzger ME, Donahue RE, Tisdale JF.
    Stem Cells; 2004 Jun; 22(6):1062-9. PubMed ID: 15536196
    [Abstract] [Full Text] [Related]

  • 5. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
    Lebensburger J, Persons DA.
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
    [Abstract] [Full Text] [Related]

  • 6. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G, Malik P.
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [Abstract] [Full Text] [Related]

  • 7. Gene therapy for homozygous beta-thalassemia. Is it a reality?
    Boulad F, Rivière I, Sadelain M.
    Hemoglobin; 2009 Jul; 33 Suppl 1():S188-96. PubMed ID: 20001625
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Future prospects for treatment of hemoglobinopathies.
    Stamatoyannopoulos JA.
    West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285
    [Abstract] [Full Text] [Related]

  • 15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 16. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
    Hernández-Boluda JC, Carreras E, Cervantes F, Marín P, Arellano-Rodrigo E, Rovira M, Solé F, Lloveras E, Espinet B, Ocejo A, Montserrat E.
    Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Collection of hematopoietic stem cells from patients with autoimmune diseases.
    Burt RK, Fassas A, Snowden J, van Laar JM, Kozak T, Wulffraat NM, Nash RA, Dunbar CE, Arnold R, Prentice G, Bingham S, Marmont AM, McSweeney PA.
    Bone Marrow Transplant; 2001 Jul; 28(1):1-12. PubMed ID: 11498738
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.